AUTO-GENERATED · CITATION-ONLY · 2026-08-07
$IOVA — convergence catalyst
Convergence score: 19 ·
Signals fired: 9
(alpha;stocktwits;gap;biotech;sec_fda;gamma;auto_sic_sector_map;auto_macro_move_index;auto_macro_vix_complex) ·
Conviction: WATCH
Auto-generated from public filings. This is not financial advice.
Confirm independently before trading. Catalyst Edge holds positions consistent
with our published signals — see
trust report.
Citation block only. Automated narrative unavailable this cycle (reason: no_citations_in_summary).
Sources
- [1] ALPHAVANTAGE · IOVA Stock Grants Signal Aggressive Post-Amtagvi Expansion · 2026-08-06T13:43:35
- [2] ALPHAVANTAGE · Why Did IOVA Stock Gain Pre-Market Today? · 2026-07-18T17:40:31
- [3] ALPHAVANTAGE · Iovance Biotherapeutics (IOVA) Heads Into Earnings With Its T Cell Therapy Story And Valuation In Focus · 2026-08-01T15:09:23
- [4] ALPHAVANTAGE · Earnings Flash (IOVA) Iovance Biotherapeutics, Inc. Reports Q2 Revenue $99.3M, vs. FactSet Est of $87.8M · 2026-08-06T11:43:35
- [5] ALPHAVANTAGE · Iovance Biotherapeutics (NASDAQ:IOVA) shares jump 18% as Amtagvi sales test approaches · 2026-07-18T13:40:31
- [6] Catalyst Edge convergence detector · Convergence score 19, 9 signals fired: alpha, stocktwits, gap, biotech, sec_fda, gamma, auto_sic_sector_map, auto_macro_move_index, auto_macro_vix_complex · 2026-08-07T16:29:53
Underlying signal breakdown
| Field | Value |
|---|
| convergence_score | 19 |
| conviction_level | WATCH |
| signal_count | 9 |
| sector | biotech |
| price | |
⚠️ Position disclosure: Catalyst Edge holds
a small live equity position in tickers that pass the convergence + scoop
publish gate. Real-time P/L, fills, and the running ledger are public at
/trust/. Specific entry
on
IOVA: see
/scoreboard/
for outcome tracking. Bloomberg legally cannot disclose this; we do.